Study: Sponsors often submit different clinical evidence to FDA, EMA, for cell and gene therapies
Regulatory NewsJeff Craven
Biologics/ biosimilars/ vaccinesBiotechnologyClinical TrialsEuropeEuropean Medicines Agency (EMA)Submission and registrationUnited StatesUS Food and Drug Administration (FDA)